Management of Adenomyosis with Menstrual-Related RLQ Pain and Constipation
This patient's menstrual-related RLQ pain with adenomyosis and constipation should be managed with a levonorgestrel-releasing intrauterine system (LNG-IUS) as first-line therapy, combined with NSAIDs for pain control and aggressive constipation management. 1, 2
Clinical Reasoning
The key diagnostic features here are:
- Cyclical RLQ pain worsening with menses strongly suggests gynecologic etiology (adenomyosis) rather than appendicitis or other acute pathology
- Negative ultrasound for appendicitis effectively rules out acute surgical abdomen 3
- Confirmed adenomyosis on imaging provides the diagnosis
- Constipation may be contributing to or exacerbating the pain, and can be associated with adenomyosis itself
The lumbar arthritis is likely a separate issue and should not drive the primary management of the RLQ pain given the clear menstrual relationship.
Treatment Algorithm
First-Line Medical Management
Hormonal suppression with LNG-IUS is the most evidence-based approach:
- LNG-IUS has demonstrated effectiveness specifically for adenomyosis symptoms 1, 2, 4
- Provides both pain relief and reduction in heavy menstrual bleeding
- Allows fertility preservation if desired at age 37
- Can be maintained long-term with minimal systemic side effects
Adjunctive Therapies
NSAIDs for pain control:
- Use scheduled dosing during menstrual periods rather than as-needed
- Addresses both adenomyosis-related pain and potential bowel-related discomfort 1
Aggressive constipation management:
- Constipation worsening around menses suggests hormonal influence on bowel motility
- Regular fiber supplementation, adequate hydration, and osmotic laxatives as needed
- Consider that constipation may be contributing to RLQ pain independent of adenomyosis
Second-Line Options if LNG-IUS Fails
If symptoms persist after 3-6 months of LNG-IUS:
- Dienogest (progestin therapy) - particularly effective for pain-dominant symptoms 5, 1, 4
- Continuous oral contraceptives - suppresses menstruation entirely 4
- GnRH antagonists for short-term use (3-6 months) followed by maintenance therapy 5, 4
Important Caveats
Rule out bowel endometriosis: While adenomyosis is confirmed, the combination of RLQ pain, constipation, and menstrual worsening could indicate concurrent bowel endometriosis 6, 7. If symptoms don't improve with hormonal therapy, consider:
- Expanded protocol transvaginal ultrasound specifically for deep endometriosis 8
- MRI pelvis with bowel preparation if not already done with endometriosis protocol
- Gastroenterology referral if bowel symptoms predominate
The constipation pattern matters: Cyclical constipation worsening with menses suggests endometriosis involving the rectosigmoid, which occurs in up to 37% of endometriosis cases and can coexist with adenomyosis 7. Non-cyclical constipation is more likely related to the lumbar arthritis (reduced mobility, pain medications) or dietary factors.
Avoid premature surgery: Hysterectomy remains definitive treatment but should be reserved for medical therapy failures given the patient's age and potential fertility desires 1, 2. Surgical excision of adenomyosis is technically challenging with high recurrence rates.
Monitoring Response
Reassess at 3 months:
- If significant improvement: continue current therapy
- If partial improvement: optimize dosing or add adjunctive therapy
- If no improvement: reconsider diagnosis (evaluate for bowel endometriosis) and escalate to second-line options
The lumbar arthritis should be managed separately by appropriate specialists, though NSAIDs used for adenomyosis may provide dual benefit.